SHANGHAI, June 15, 2021 /PRNewswire/ -- Viva Biotech (01873.HK) declared today that Totient, one of its portfolio companies, has been acquired by AbSci, a synthetic biology company unlocking the ...
COSTA MESA, Calif., July 9, 2021 /PRNewswire/ -- CerraCap Ventures, a leading early-stage Venture Fund, today announced acquisition of its portfolio company Totient by Absci for an undisclosed amount.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback